We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS: Part D Plans Will Allow Indication-Based Formularies in 2020
CMS: Part D Plans Will Allow Indication-Based Formularies in 2020
In the latest CMS move aimed at reducing drug prices, Administrator Seema Verma released new guidance on how Part D plan sponsors can negotiate formulary coverage based on specific indications starting in 2020.